BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23842471)

  • 1. Prevalence, incidence and risk factors for anogenital warts in Sub Saharan Africa: a systematic review and meta analysis.
    Banura C; Mirembe FM; Orem J; Mbonye AK; Kasasa S; Mbidde EK
    Infect Agent Cancer; 2013 Jul; 8(1):27. PubMed ID: 23842471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of the incidence and prevalence of genital warts.
    Patel H; Wagner M; Singhal P; Kothari S
    BMC Infect Dis; 2013 Jan; 13():39. PubMed ID: 23347441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Epidemiological Characteristics of Anogenital Warts Among Recently Diagnosed HIV-Positive Women on Antiretroviral Therapy in Lagos, Nigeria.
    Adefemi AK; Okunowo AA; Anorlu RI
    Cureus; 2024 Mar; 16(3):e56251. PubMed ID: 38623132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade Dysplasia in Anogenital Warts of HIV-Positive Men.
    Kreuter A; Siorokos C; Oellig F; Silling S; Pfister H; Wieland U
    JAMA Dermatol; 2016 Nov; 152(11):1225-1230. PubMed ID: 27463201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.
    Bruni L; Albero G; Rowley J; Alemany L; Arbyn M; Giuliano AR; Markowitz LE; Broutet N; Taylor M
    Lancet Glob Health; 2023 Sep; 11(9):e1345-e1362. PubMed ID: 37591583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Cervico-vaginal High-risk HPV Types and Other Sexually Transmitted Pathogens in Anogenital Warts Patients.
    Mortaki D; Tsitsopoulos E; Louizou E; Tsiambas E; Peschos D; Sioulas V; Galanos A; Tagka A; Gregoriou S; Stratigos A; Rigopoulos D; Nicolaidou E
    Anticancer Res; 2020 Apr; 40(4):2219-2223. PubMed ID: 32234917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi.
    Taha TE; Dallabetta GA; Hoover DR; Chiphangwi JD; Mtimavalye LA; Liomba GN; Kumwenda NI; Miotti PG
    AIDS; 1998 Jan; 12(2):197-203. PubMed ID: 9468369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of human papillomavirus on anogenital warts in Portugal - The HERCOLES study.
    Azevedo J; Pista A; Lisboa C; Santo I; Azevedo L; Cunha MJ;
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1342-1348. PubMed ID: 28485812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
    Park IU; Introcaso C; Dunne EF
    Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current status of the female condom in Africa].
    Deniaud F
    Sante; 1997; 7(6):405-15. PubMed ID: 9503499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anal dysplasia screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could the human papillomavirus vaccine prevent recurrence of ano-genital warts?: a systematic review and meta-analysis.
    Husein-ElAhmed H
    Int J STD AIDS; 2020 Jun; 31(7):606-612. PubMed ID: 32438856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number of external anogenital warts is associated with the occurrence of abnormal cervical cytology.
    Chayachinda C; Boriboonhirunsarn D; Thamkhantho M; Nuengton C; Chalermchockcharoenkit A
    Asian Pac J Cancer Prev; 2014; 15(3):1177-80. PubMed ID: 24606437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health service utilisation for anogenital warts in Ontario, Canada prior to the human papillomavirus (HPV) vaccine programme introduction: a retrospective longitudinal population-based study.
    Guerra FM; Rosella LC; Dunn S; Wilson SE; Chen C; Deeks SL
    BMJ Open; 2016 Mar; 6(3):e009914. PubMed ID: 26966057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of genital infections in medical inpatients in Blantyre, Malawi.
    Maher D; Hoffman I
    J Infect; 1995 Jul; 31(1):77-8. PubMed ID: 8522842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS in sub-Saharan Africa: the epidemiology of heterosexual transmission and the prospects for prevention.
    Hunter DJ
    Epidemiology; 1993 Jan; 4(1):63-72. PubMed ID: 8420583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of the treatment of active anogenital warts with human papillomavirus vaccines.
    Villemure SE; Wilby KJ
    J Am Pharm Assoc (2003); 2024; 64(1):179-185.e3. PubMed ID: 38453661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, Incidence, and Clearance of Anogenital Warts in Kenyan Men Reporting High-Risk Sexual Behavior, Including Men Who Have Sex With Men.
    Neme S; Wahome E; Mwashigadi G; Thiong'o AN; Stekler JD; Wald A; Sanders EJ; Graham SM
    Open Forum Infect Dis; 2015 Apr; 2(2):ofv070. PubMed ID: 26110169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.
    Thurgar E; Barton S; Karner C; Edwards SJ
    Health Technol Assess; 2016 Mar; 20(24):v-vi, 1-486. PubMed ID: 27034016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Declining HIV incidence in sub-Saharan Africa: a systematic review and meta-analysis of empiric data.
    Joshi K; Lessler J; Olawore O; Loevinsohn G; Bushey S; Tobian AAR; Grabowski MK
    J Int AIDS Soc; 2021 Oct; 24(10):e25818. PubMed ID: 34672104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.